clock menu more-arrow no yes

Biotech Falls on Clinton 'Price Gouging' Comments

The major biotech ETF fell to its lows of the day after Democratic presidential hopeful Hillary Clinton said Monday she would take on “price gouging” in the pharmaceutical industry.

A Sunday New York Times article told of a specialty drug that went from $13.50 to $750 per tablet overnight. Responding on Twitter to this piece, Clinton said Monday she will propose a fix to the situation on Tuesday.

Read the rest of this post on the original site »

This article originally appeared on Recode.net.